Thus, strategies aimed at reducing reactive oxygen species (ROS) production and enhancing acetylcholine (ACh) production through inhibition of acetylcholinesterase (AChE) activity or increased ChAT activity are pivotal in AD treatment. The gene discussed is ACHE; the disease is Alzheimer disease.